BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24972516)

  • 1. [Collagenase-A revolution of Dupuytren's therapy].
    Frueh FS; Calcagni M
    Ther Umsch; 2014 Jul; 71(7):379-84. PubMed ID: 24972516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Dupuytren's disease - patient satisfaction and functional results one year after partial fasciectomy and injection of collagenase].
    Vollbach FH; Walle L; Fansa H
    Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):258-64. PubMed ID: 24089298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-centre cost comparison analysis of collagenase injection versus surgical fasciectomy for Dupuytren's contracture of the hand.
    Mehta S; Belcher HJ
    J Plast Reconstr Aesthet Surg; 2014 Mar; 67(3):368-72. PubMed ID: 24486152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagenase injection as nonsurgical treatment of Dupuytren's disease: 8-year follow-up.
    Watt AJ; Curtin CM; Hentz VR
    J Hand Surg Am; 2010 Apr; 35(4):534-9, 539.e1. PubMed ID: 20353858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Range of motion, postoperative rehabilitation and patient satisfaction in MCP and PIP joints affected by Dupuytren Tubiana stage 1-3: collagenase enzymatic fasciotomy or limited fasciectomy? A clinical study in 52 patients.
    Leclère FM; Kohl S; Varonier C; Unglaub F; Vögelin E
    Arch Orthop Trauma Surg; 2018 Nov; 138(11):1623-1631. PubMed ID: 30259125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme injection as nonsurgical treatment of Dupuytren's disease.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2000 Jul; 25(4):629-36. PubMed ID: 10913202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical fasciectomy versus collagenase injection in treating recurrent Dupuytren disease: study protocol of a randomised controlled trial.
    Nordenskjöld J; Lauritzson A; Waldén M; Kopylov P; Atroshi I
    BMJ Open; 2019 Feb; 9(2):e024424. PubMed ID: 30808670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness in the management of Dupuytren's contracture. A Canadian cost-utility analysis of current and future management strategies.
    Baltzer H; Binhammer PA
    Bone Joint J; 2013 Aug; 95-B(8):1094-100. PubMed ID: 23908426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison between Collagenase Injection and Partial Fasciectomy in the Treatment of Dupuytren's Contracture.
    Tay TK; Tien H; Lim EY
    Hand Surg; 2015 Oct; 20(3):386-90. PubMed ID: 26387998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Costs for collagenase injections compared with fasciectomy in the treatment of Dupuytren's contracture: a retrospective cohort study.
    Atroshi I; Strandberg E; Lauritzson A; Ahlgren E; Waldén M
    BMJ Open; 2014 Jan; 4(1):e004166. PubMed ID: 24435894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of Dupuytren's disease with collagenase injections in Germany: efficacy and adverse effects in 110 treated joints].
    Pototschnig A; Volkmer E; Giunta RE
    Handchir Mikrochir Plast Chir; 2017 Aug; 49(3):154-161. PubMed ID: 28806826
    [No Abstract]   [Full Text] [Related]  

  • 12. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.
    Lauritzson A; Atroshi I
    BMJ Open; 2017 Mar; 7(3):e012943. PubMed ID: 28298365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Collagenase clostridium histolyticum for the treatment of Dupuytren's contracture: systematic review and economic evaluation.
    Brazzelli M; Cruickshank M; Tassie E; McNamee P; Robertson C; Elders A; Fraser C; Hernandez R; Lawrie D; Ramsay C
    Health Technol Assess; 2015 Oct; 19(90):1-202. PubMed ID: 26524616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year results of needle fasciotomy and collagenase injection in treatment of Dupuytren's contracture: A two-centre prospective randomized clinical trial.
    Scherman P; Jenmalm P; Dahlin LB
    J Hand Surg Eur Vol; 2016 Jul; 41(6):577-82. PubMed ID: 26631343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [News in the treatment of Dupuytren's disease: from surgery to collagenase's injection].
    Cuylits N
    Rev Med Brux; 2013 Sep; 34(4):283-6. PubMed ID: 24195241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple collagenase injections are safe for treatment of Dupuytren's contractures.
    Gajendran VK; Hentz V; Kenney D; Curtin CM
    Orthopedics; 2014 Jul; 37(7):e657-60. PubMed ID: 24992063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Collagenase in the treatment of Dupuytren's disease: an in vitro study.
    Starkweather KD; Lattuga S; Hurst LC; Badalamente MA; Guilak F; Sampson SP; Dowd A; Wisch D
    J Hand Surg Am; 1996 May; 21(3):490-5. PubMed ID: 8724485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost Comparison of Collagenase Clostridium Histolyticum and Fasciectomy for Treatment of Dupuytren's Contracture in the Australian Health System.
    Sefton AK; Smith BJ; Stewart DA
    J Hand Surg Asian Pac Vol; 2018 Sep; 23(3):336-341. PubMed ID: 30282551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of collagenase treatment for Dupuytren's disease: 2-year follow-up results.
    Van Beeck A; Van den Broek M; Michielsen M; Didden K; Vuylsteke K; Verstreken F
    Hand Surg Rehabil; 2017 Oct; 36(5):346-349. PubMed ID: 28732844
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.